| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
|
Mol Cancer Res
|
2007
|
2.00
|
|
2
|
MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
|
Cancer Res
|
2008
|
1.77
|
|
3
|
Structure, evolution, and biology of the MUC4 mucin.
|
FASEB J
|
2007
|
1.75
|
|
4
|
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
|
Mod Pathol
|
2006
|
1.55
|
|
5
|
Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms.
|
FEMS Microbiol Lett
|
2006
|
1.51
|
|
6
|
MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.
|
Carcinogenesis
|
2011
|
1.39
|
|
7
|
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.
|
PLoS One
|
2011
|
1.27
|
|
8
|
An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
|
J Biol Chem
|
2013
|
1.22
|
|
9
|
Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells.
|
Prostate
|
2007
|
1.17
|
|
10
|
MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.
|
Cancer Res
|
2008
|
1.13
|
|
11
|
Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.
|
Mol Cancer Ther
|
2011
|
1.10
|
|
12
|
Characterization of human mucin MUC17. Complete coding sequence and organization.
|
J Biol Chem
|
2006
|
1.04
|
|
13
|
Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.
|
Cancer Res
|
2005
|
1.03
|
|
14
|
CXCL8 and its cognate receptors in melanoma progression and metastasis.
|
Future Oncol
|
2010
|
1.02
|
|
15
|
Human glycemic response and phenolic content of unsweetened cranberry juice.
|
J Med Food
|
2008
|
1.01
|
|
16
|
Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
|
Carcinogenesis
|
2012
|
1.00
|
|
17
|
MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs.
|
Mol Cell Pharmacol
|
2010
|
0.99
|
|
18
|
Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.
|
Cancer Lett
|
2007
|
0.97
|
|
19
|
Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways.
|
Oncogene
|
2005
|
0.97
|
|
20
|
Hoffa fracture with ipsilateral patellar dislocation resulting from household trauma.
|
Can J Surg
|
2009
|
0.95
|
|
21
|
Dysregulated expression of MIC-1/PDF in human prostate tumor cells.
|
Biochem Biophys Res Commun
|
2003
|
0.95
|
|
22
|
Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model.
|
Drug Des Devel Ther
|
2009
|
0.94
|
|
23
|
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.
|
Microvasc Res
|
2011
|
0.94
|
|
24
|
Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment.
|
Pharm Res
|
2007
|
0.93
|
|
25
|
Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells.
|
Int J Oncol
|
2011
|
0.92
|
|
26
|
Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas.
|
Pancreas
|
2006
|
0.92
|
|
27
|
Tracing the history of plant traits under domestication in cranberries: potential consequences on anti-herbivore defences.
|
J Exp Bot
|
2011
|
0.89
|
|
28
|
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma.
|
J Pediatr Hematol Oncol
|
2011
|
0.85
|
|
29
|
Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential.
|
Curr Drug Targets
|
2013
|
0.85
|
|
30
|
Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
|
J Biomed Nanotechnol
|
2016
|
0.82
|
|
31
|
Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice.
|
PLoS One
|
2011
|
0.81
|
|
32
|
Influence of silicon on resistance of Zinnia elegans to Myzus persicae (Hemiptera: Aphididae).
|
Environ Entomol
|
2009
|
0.80
|
|
33
|
Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves.
|
Phytother Res
|
2007
|
0.79
|
|
34
|
The specific degree-of-polymerization of A-type proanthocyanidin oligomers impacts Streptococcus mutans glucan-mediated adhesion and transcriptome responses within biofilms.
|
Biofouling
|
2013
|
0.79
|
|
35
|
Urinary Clearance of Cranberry Flavonol Glycosides in Humans.
|
J Agric Food Chem
|
2016
|
0.78
|
|
36
|
Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes.
|
J Food Sci
|
2010
|
0.78
|
|
37
|
Developmental potency of pre-implant parthenogenetic goat embryos: effect of activation protocols and culture media.
|
In Vitro Cell Dev Biol Anim
|
2013
|
0.78
|
|
38
|
Rare excitatory amino acid from flowers of zonal geranium responsible for paralyzing the Japanese beetle.
|
Proc Natl Acad Sci U S A
|
2011
|
0.75
|
|
39
|
Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells.
|
Chem Biol Drug Des
|
2011
|
0.75
|
|
40
|
Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens.
|
Pancreas
|
2017
|
0.75
|
|
41
|
Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens.
|
Pancreas
|
2017
|
0.75
|